BioLargo Subsidiary Clyra Medical Advances Product Distribution Through a Series of Agreements

Stock Information for Inhibikase Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Inhibikase Therapeutics Inc.

Independent Evaluation Confirms Breakthrough Performance of BioLargo's Cellinity Battery Technology for Grid-Scale Energy Storage
Sidoti Events, LLC's Virtual May Micro-Cap Conference
BioLargo Q1 2025 Earnings Results Webcast and Conference Call on Thursday, May 15, 2025 - 4:30 PM Eastern Time
BioLargo's PFAS Solution Provides Dramatic Long-Term Cost Savings Compared with Incumbent Technologies
AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing
BioLargo to Present at the LD Micro Invitational XV
Gabelli Funds to Host 11th Annual Waste & Sustainability Symposium Thursday, April 3, 2025
Cleantech Innovator BioLargo Reports Record Revenues in 2024 Annual Report

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.